Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stroke: an update.

Literature DB >> 25099511

Stroke: an update.

Abstract

Cerebrovascular diseases are one of the favorite topics of manuscripts submitted to the Journal of Neurology. In this summary paper, we briefly present those manuscripts that in our opinion were most relevant in selected areas of vascular diseases of the brain.

Entities: Disease

Mesh：

Year: 2014 PMID： 25099511 DOI： 10.1007/s00415-014-7447-z

Source DB: PubMed Journal: J Neurol ISSN： 0340-5354 Impact factor: 4.849

Keyword Cloud
References

30 in total

1. No evidence for an association between genetic variation at the MMP2 and MMP9 loci and aneurysmal subarachnoid haemorrhage.

Authors: Sandra Olsson; Ludvig Z Csajbok; Katarina Jood; Karin Nylén; Bengt Nellgård; Christina Jern
Journal: J Neurol Date: 2011-07-07 Impact factor: 4.849

2. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.

Authors: Marius Ringelstein; Alexander Jung; Klaus Berger; Monika Stoll; Katharina Madlener; Christof Klötzsch; Felix Schlachetzki; Erwin Stolz
Journal: J Neurol Date: 2012-04-12 Impact factor: 4.849

3. Time intervals from subarachnoid hemorrhage to rebleed.

Authors: M R Germans; B A Coert; W P Vandertop; D Verbaan
Journal: J Neurol Date: 2014-05-08 Impact factor: 4.849

4. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry.

Authors: Susanna Horner; Kurt Niederkorn; Thomas Gattringer; Martin Furtner; Raffi Topakian; Wilfried Lang; Robert Maier; Andreas Gamillscheg; Franz Fazekas
Journal: J Neurol Date: 2012-08-05 Impact factor: 4.849

5. Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis.

Authors: Mayi Gnofam; Didier Leys; Nelly Ponchelle-Dequatre; Marie Bodenant; Hilde Hénon; Régis Bordet; Charlotte Cordonnier
Journal: J Neurol Date: 2013-08-14 Impact factor: 4.849

Stroke: an update.

1. No evidence for an association between genetic variation at the MMP2 and MMP9 loci and aneurysmal subarachnoid haemorrhage.

2. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.

3. Time intervals from subarachnoid hemorrhage to rebleed.

4. Management of right-to-left shunt in cryptogenic cerebrovascular disease: results from the observational Austrian paradoxical cerebral embolism trial (TACET) registry.

5. Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis.

6. Prevalence of cortical superficial siderosis in patients with cognitive impairment.

7. Clinical impact and predictors of carotid artery in-stent restenosis.

8. Increased expression of endothelial lipase in symptomatic and unstable carotid plaques.

9. Decompressive hemicraniectomy followed by endovascular thrombosuction in a patient with cerebral venous thrombosis.

10. Chance of aneurysm in patients suspected of SAH who have a 'negative' CT scan but a 'positive' lumbar puncture.